Endocrine System Diseases Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya, Aichi, Japan
  • +43 more
2022-04-06
Apr 6, 2022
A
Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo
  • San Francisco, California
  • +20 more
2022-03-28
Mar 28, 2022
C
Recruiting
  • Diabetes Mellitus
  • +6 more
  • VCTX210A unit
  • Edmonton, Alberta, Canada
  • +2 more
2022-04-01
Apr 1, 2022
D
Recruiting
  • Diabetes Mellitus, Type 1
  • +10 more
  • Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
  • +2 more
  • Hradec Kralove, Czechia
  • +30 more
2022-03-17
Mar 17, 2022
G
Completed
  • Kidney Diseases
  • +4 more
  • San Antonio, Texas
    Worldwide Clinical Trials
2022-03-24
Mar 24, 2022
H
Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +78 more
2022-03-16
Mar 16, 2022
S
Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2022-03-15
Mar 15, 2022
V
Not yet recruiting
  • Thyroid Eye Disease
  • +11 more
  • (no location specified)
2022-03-02
Mar 2, 2022
F
Recruiting
  • Diabetes Mellitus
  • +4 more
  • A digital foot self-management program
  • Kaohsiung, Taiwan
    Fooyin University
2022-02-28
Feb 28, 2022
T
Recruiting
  • Child With Cancer
  • +3 more
  • Brief Hope Intervention
  • Hong Kong, China
    School of Nursing, The Hong Kong Polytechnic University
2022-02-25
Feb 25, 2022
A
Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo for TransCon PTH
  • Chicago, Illinois
  • +14 more
2022-03-02
Mar 2, 2022
R
Recruiting
  • Polycystic Ovary Syndrome
  • +3 more
  • Dehydroepiandrosterone (DHEA)
  • 11-ketoandrostenedione (11KA4)
  • Dublin 9, Ireland
    Beaumont Hospital
2022-02-21
Feb 21, 2022
H
Active, not recruiting
  • Cardiovascular Diseases
  • +8 more
  • Dietary intake
  • (no location specified)
2022-02-28
Feb 28, 2022
U
Recruiting
  • Type 1 Diabetes Mellitus
  • +4 more
  • Tandem t:slim X2 insulin pump with Control IQ technology
  • Calgary, Alberta, Canada
  • +1 more
2022-02-08
Feb 8, 2022
V
Terminated
  • Spinal Cord Injury
  • +10 more
  • testosterone enanthate, finasteride
  • placebo
  • Tampa, Florida
  • +1 more
2022-02-07
Feb 7, 2022
S
Active, not recruiting
  • Endocrine System Diseases
  • +5 more
  • Blood test
  • Budapest, Pest, Hungary
    Heart and Vascular Center
2022-01-07
Jan 7, 2022
S
Active, not recruiting
  • Endocrine System Diseases
  • +3 more
    • Budapest, Hungary
    • +2 more
    2022-01-07
    Jan 7, 2022
    U
    Recruiting
    • Thyroid Neoplasms
    • +8 more
    • PTeye
    • Ann Arbor, Michigan
      The University of Michigan
    2022-01-05
    Jan 5, 2022
    A
    Completed
    • Growth Hormone Deficiency, Pediatric
    • +3 more
    • TransCon hGH
    • Birmingham, Alabama
    • +23 more
    2021-12-07
    Dec 7, 2021
    A
    Completed
    • Growth Hormone Deficiency, Pediatric
    • +4 more
    • Once weekly subcutaneous injection of TransCon hGH
    • Once daily subcutaneous injection of Genotropin
    • Birmingham, Alabama
    • +52 more
    2021-12-06
    Dec 6, 2021
    A
    Recruiting
    • Adult Growth Hormone Deficiency
    • +2 more
    • Las Vegas, Nevada
      Ascendis Pharma Investigational Site
    2021-12-28
    Dec 28, 2021
    V
    Recruiting
    • Diabetes Mellitus
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    2021-11-18
    Nov 18, 2021